Ki Summary BindingDB logo
myBDB logout
Reaction Details
Report a problem with these data
TargetGalectin-3
LigandBDBM468298
Substrate/Competitorn/a
Meas. Tech.Evaluation of Kd Values
Kd 2.00±n/a nM
Citation Leffler, HNilsson, UZetterberg, F Hybrid galactoside inhibitor of galectins US Patent US10800804 Publication Date 10/13/2020
More Info.:Get all data from this article,  Assay Method
 
Galectin-3
Name:Galectin-3
Synonyms:LEG3_HUMAN | LGALS3 | MAC2
Type:Enzyme
Mol. Mass.:26156.54
Organism:Homo sapiens (Human)
Description:P17931
Residue:250
Sequence:
MADNFSLHDALSGSGNPNPQGWPGAWGNQPAGAGGYPGASYPGAYPGQAPPGAYPGQAPP
GAYPGAPGAYPGAPAPGVYPGPPSGPGAYPSSGQPSATGAYPATGPYGAPAGPLIVPYNL
PLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNN
WGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDI
DLTSASYTMI
Blast this sequence in BindingDB or PDB
  Blast E-value cutoff:
BDBM468298
n/a
NameBDBM468298
Synonyms:US10800804, Example 3c
TypeSmall organic molecule
Emp. Form.C28H28F4N6O8S
Mol. Mass.684.616
SMILESOCC1O[C@@H](SC2O[C@H](CO)C(O)C([C@H]2O)n2cc(nn2)-c2cc(F)cc(F)c2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)cc(F)c1 |r|
Structure
Search PDB for entries with ligand similarity:Similarity to this molecule at least: